Psychedelics Today17 Mar 2023

Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills Introduced in VT, and Ketamine Telehealth Uncertainty

In this episode of Psychedelics Weekly, Joe and Kyle join up once again to discuss the news and articles they found the most interesting this week.

They start with the business news everyone is talking about: Field Trip Health & Wellness closing 5 of their clinics due to financial struggles (a deficit of $48.7 million since their inception and a net loss of $6.9 million reported for the last quarter), little confidence they'd be able to receive more funding, and the changing landscape of ketamine telehealth now that the Covid Public Health Emergency should finally come to an end in May. They also highlight an article dissecting the collapse of Synthesis Institute and the lessons to be learned, with both stories really showing just how new and unstable psychedelic business still is, and how the allure of first-mover advantage can be a dangerous gamble.

They also discuss four drug reform bills introduced in Vermont: two of which would decriminalize simple possession of all drugs, making a "personal use supply of drugs" a civil offense with a $50 fine; one removing penalties for using or selling psilocybin; and the last decriminalizing certain psychedelic plants and fungi.

And they look at a research study aiming to learn more about people's lives after they've been involved in a clinical trial, Time Magazine's article about psychedelics and couples therapy, and a study that found that while 64% of survey respondents said at-home ketamine helped their symptoms, 55% (and 58% of Millennials) said they used more than the recommended dose – either by accident or on purpose.

www.psychedelicstoday.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(774)

PT 624 - Dr. Cat Meyer - Sex, Love, Psychedelics

In this episode of Psychedelics Today, Joe Moore sits down with Dr. Cat Meyer, licensed psychotherapist, sex therapist, and host of Sex, Love, Psychedelics. Together, they explore the deep intersectio...

23 Sep 20251h 18min

PT 623 - Dee Dee Goldpaugh - Embracing Pleasure

Joe Moore interviews Dee Dee Goldpaugh, LCSW about their new book Embrace Pleasure: How Psychedelics Can Heal Our Sexuality. The discussion covers the book's reception, critiques of over-medicalizatio...

16 Sep 20251h 17min

PT 622 - Matt Xavier - The Psychedelic DJ

From the Rave Scene to Psychedelic Therapy In this episode, Kyle Buller speaks with Matt Xavier, DJ, therapist, and author. The conversation took place live at Psychedelic Science. Matt recalls hi...

26 Aug 20251h 5min

PT 621 - Dr Case Newsom - Zendo Project

In this episode, Joe Moore sits down with Dr. Case Newsom, an emergency room physician in Denver and Medical Director for both Zendo Project and Stadium Medical. They explore how psychedelic harm redu...

21 Aug 20251h 17min

PT 620 - Kat Murti – Students for Sensible Drug Policy, Meta Censorship, and the Fight for Science

In this episode, Joe Moore is joined by Kat Murti, Executive Director of Students for Sensible Drug Policy (SSDP), the largest youth-led network working to end the war on drugs. SSDP organizes at the ...

18 Aug 20251h 20min

PT 619 - Sphinx Gate with Mareesa Stertz and Tania Abdul

In this episode, Joe Moore is joined by Mareesa Stertz and Tania Abdul, the visionaries behind Sphinx Gate, one of Burning Man 2025's most ambitious and mythic art installations. Inspired by The Never...

31 Jul 20251h 8min

PT 618 - Chad Charles - Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

In this episode of Psychedelics Today, Joe Moore sits down with Chad Charles — educator, mentor, and practitioner specializing in 5-MeO-DMT therapy. Chad shares his decade-long journey working with 5-...

29 Jul 20251h 13min

PT 617 - Alan Davis - Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine's Potential

In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic pot...

24 Jul 20251h 15min